rs11300320
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP6_Moderate
The NM_000153.4(GALC):c.1162-5_1162-4delTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000752 in 1,277,986 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00085 ( 0 hom. )
Consequence
GALC
NM_000153.4 splice_region, intron
NM_000153.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.817
Publications
7 publications found
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
GALC Gene-Disease associations (from GenCC):
- Krabbe diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
BP6
Variant 14-87950751-GAA-G is Benign according to our data. Variant chr14-87950751-GAA-G is described in ClinVar as Likely_benign. ClinVar VariationId is 752088.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GALC | NM_000153.4 | c.1162-5_1162-4delTT | splice_region_variant, intron_variant | Intron 10 of 16 | ENST00000261304.7 | NP_000144.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000669 AC: 1AN: 149412Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
149412
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000579 AC: 123AN: 212618 AF XY: 0.000666 show subpopulations
GnomAD2 exomes
AF:
AC:
123
AN:
212618
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000851 AC: 960AN: 1128574Hom.: 0 AF XY: 0.000845 AC XY: 481AN XY: 568936 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
960
AN:
1128574
Hom.:
AF XY:
AC XY:
481
AN XY:
568936
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
16
AN:
27408
American (AMR)
AF:
AC:
18
AN:
38246
Ashkenazi Jewish (ASJ)
AF:
AC:
8
AN:
21656
East Asian (EAS)
AF:
AC:
9
AN:
33782
South Asian (SAS)
AF:
AC:
63
AN:
69818
European-Finnish (FIN)
AF:
AC:
9
AN:
47558
Middle Eastern (MID)
AF:
AC:
1
AN:
4810
European-Non Finnish (NFE)
AF:
AC:
799
AN:
837868
Other (OTH)
AF:
AC:
37
AN:
47428
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.248
Heterozygous variant carriers
0
160
320
481
641
801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000669 AC: 1AN: 149412Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 72702 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
149412
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
72702
show subpopulations
African (AFR)
AF:
AC:
1
AN:
40644
American (AMR)
AF:
AC:
0
AN:
14894
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3460
East Asian (EAS)
AF:
AC:
0
AN:
5088
South Asian (SAS)
AF:
AC:
0
AN:
4740
European-Finnish (FIN)
AF:
AC:
0
AN:
10012
Middle Eastern (MID)
AF:
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67296
Other (OTH)
AF:
AC:
0
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Galactosylceramide beta-galactosidase deficiency Benign:1
Apr 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.